home / stock / apen / apen news

APEN News and Press, Apollo Endosurgery Inc. From 07/21/22

Stock Information
Company Name: Apollo Endosurgery Inc.
Stock Symbol: APEN
Market: NASDAQ
Website: apolloendo.com
Menu
APEN APEN Quote APEN Short APEN News APEN Articles APEN Message Board
Get APEN Alerts

News, Short Squeeze, Breakout and More Instantly...
APEN - Apollo Endosurgery to Report Second Quarter Results on August 2, 2022

AUSTIN, TX / ACCESSWIRE / July 21, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release financial re...
APEN - Hot Penny Stocks to Watch Right Now? 3 For Your July List

3 Hot Penny Stocks to Watch in July 2022 With penny stocks and blue chips falling during trading today, there is a lot that investors need to know. The reason for the stock market falling right now is due to a new inflation report that came out detailing higher than expected prices. In ...

APEN - APEN, COE and BVS among mid-day movers

Gainers: ironSource ( IS ) +48% . Liberty TripAdvisor Holdings ( LTRPB ) +47% . XORTX Therapeutics ( XRTX ) +38% . Boxed ( BOXD ) +29% . TDH Holdings ( PETZ ) +25% . Gossamer Bio ( GOSS ) +24% . Rhythm Pharmaceuti...

APEN - XORTX Therapeutics leads healthcare gainers, Humanigen and Atara Biotherapeutics among losers

Gainers: XORTX Therapeutics ( XRTX ) +39% . Gossamer Bio ( GOSS ) +24% . Rhythm Pharmaceuticals ( RYTM ) +23% . Apollo Endosurgery ( APEN ) +18% . Tyra Biosciences ( TYRA ) +15% . Losers: Humanigen ( HGEN ) -80% . Atara Biotherap...
APEN - FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG(TM) and Apollo REVISE(TM), New Endoscopic Systems for Patients with Obesity

Systems Offer Effective, Minimally Invasive Treatment Options for Millions of Patients with Obesity (BMI 30-50 kg/m 2 ) AUSTIN, TX / ACCESSWIRE / July 13, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal...

APEN - Sharon O'Keefe Joins Apollo Endosurgery Board of Directors

Seasoned healthcare leader brings 30 years of hospital system and medical technology expertise AUSTIN, TX / ACCESSWIRE / July 6, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures,...

APEN - Digestive Disease Week 2022 Adds to the Growing Wave of Clinical Evidence Supporting Significant Opportunity for Apollo Endosurgery Products

AUSTIN, TX / ACCESSWIRE / May 31, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced highlights today from data presented at Digestive Disease Week May 21-24. "With more th...
APEN - Apollo Endosurgery Products to Take Center Stage at Digestive Disease Week

AUSTIN, TX / ACCESSWIRE / May 18, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced today that Apollo products and procedures that utilize Apollo products will be featured i...

APEN - Apollo Endosurgery, Inc. (APEN) CEO Chas McKhann on Q1 2022 Results - Earnings Call Transcript

Apollo Endosurgery, Inc. (APEN) Q1 2022 Earnings Conference Call May 03, 2022 04:30 PM ET Company Participants Matt Kreps - Investor Relations Chas McKhann - Chief Executive Officer Jeff Black - Chief Financial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Chris Cool...

APEN - Apollo Endosurgery, Inc. 2022 Q1 - Results - Earnings Call Presentation

The following slide deck was published by Apollo Endosurgery, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Apollo Endosurgery, Inc. 2022 Q1 - Results - Earnings Call Presentation

Previous 10 Next 10